Skip to content
FY'25FY'24FY'23FY'22
$0+100%-$11.24M
$32.03M
-$72.78M-35.8%-$53.59M-26.9%-$42.21M+27.9%-$58.51M+8.1%
$665K-0.2%$666K+0.2%$665K0.0%$665K-0.2%
$410K-9.5%$453K-4.2%$473K-35.2%$730K+64.4%
-$1.34M-209%
$0+100%-$61K-200%
$3.21M-$1.79M
$136K$0$0-100%$2.65M-54.4%
$912K
$17.15M-84.5%$110.41M+574%$16.39M-79.5%$79.96M+26.4%
-$335K-168%-$125K-3.3%-$121K+69.8%-$401K
-$54.12M-48.9%-$36.34M-10.0%-$33.04M+29.7%-$47.01M+13.1%
-$52K
$92K$0
$0
$315K+152%$125K+3.3%$121K-69.8%$401K-8.2%
$2.49M+186%$871K-25.6%$1.17M
$395K-18.7%$486K
$21.46M+57.9%$13.59M+89.2%$7.18M+38.3%$5.19M-64.4%
-$75.86M-37.6%-$55.14M-29.9%-$42.44M+25.2%-$56.76M+8.3%
-$76.94M-36.8%-$56.26M-29.1%-$43.57M+24.9%-$58.06M+7.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Pulse Biosciences, Inc.'s revenue?
Pulse Biosciences, Inc. (PLSE) generated $751.0K in revenue over the trailing twelve months.
Is Pulse Biosciences, Inc. profitable?
Pulse Biosciences, Inc. is not currently profitable: it reported a net loss of $74.6M over the trailing twelve months, a -9929.0% net margin.
What are Pulse Biosciences, Inc.'s profit margins?
Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
Where does Pulse Biosciences, Inc.'s income statement data come from?
Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.